查看完整行情页>>
|
货币单位:美元(USD)
Mast Therapeutics, Inc. (mstx)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Sabby Management LLC |
23799222 |
9.34% |
14945022 |
168.79% |
2017-01-09
|
| Perkins Capital Management Inc |
213500 |
0.09% |
-346250 |
-61.86% |
2016-12-31
|
| BNY Mellon Investment Management |
134463 |
0.06% |
-20452 |
-13.20% |
2016-09-30
|
| KCG AMERICAS LLC |
101806 |
0.04% |
-103382 |
-50.38% |
2016-09-30
|
| State Street Corp |
54724 |
0.02% |
41600 |
316.98% |
2016-09-30
|
| BlackRock Advisors LLC |
50199 |
0.02% |
34771 |
225.38% |
2016-09-30
|
| Susquehanna Financial Group, LLLP |
46525 |
0.02% |
-33862 |
-42.12% |
2016-09-30
|
| Guggenheim Capital LLC |
46353 |
0.02% |
-447 |
-0.96% |
2016-09-30
|
| SIMPLEX TRADING, LLC |
25300 |
0.01% |
25300 |
-- |
2016-09-30
|
| Northern Trust Investments N A |
318323 |
0.14% |
111353 |
53.80% |
2016-09-30
|
| HighTower Advisors, LLC |
336098 |
0.14% |
-- |
-- |
2016-09-30
|
| Baker Bros Advisors LP |
8584051 |
3.68% |
4716025 |
121.92% |
2016-09-30
|
| Vanguard Group Inc |
7552722 |
3.24% |
1556675 |
25.96% |
2016-09-30
|
| BlackRock Fund Advisors |
1719932 |
0.74% |
1480698 |
618.93% |
2016-09-30
|
| Renaissance Technologies Corp |
1396562 |
0.60% |
565400 |
68.03% |
2016-09-30
|
| Pine River Capital Management, L.P. |
1250000 |
0.54% |
-- |
-- |
2016-09-30
|
| Geode Capital Management, LLC |
1012559 |
0.43% |
-- |
-- |
2016-09-30
|
| Credit Suisse First Boston (CSFB) |
500160 |
0.21% |
500160 |
-- |
2016-09-30
|
| Creative Planning Inc |
413401 |
0.18% |
-20354 |
-4.69% |
2016-09-30
|
| Lauolmstead LLC |
20000 |
0.01% |
-- |
-- |
2016-12-31
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| SSgA U.S. Total Market Index Fd Class I |
4016 |
-- |
-67 |
-1.64% |
2016-09-30
|
| Vanguard Extended Market Idx Inv |
2879072 |
1.21% |
401849 |
16.22% |
2016-12-31
|
| Fidelity Spartan |
146638 |
0.06% |
-- |
-- |
2016-12-31
|
| BNY Mellon EB DL Mkt Completion |
102691 |
0.04% |
-7135 |
-6.50% |
2016-12-31
|
| The Vanguard Total Stock Market Index |
102900 |
0.04% |
-- |
-- |
2016-12-31
|
| iShares Core S&P Total US Stock Mkt |
51661 |
0.02% |
-- |
-- |
2017-02-07
|
| Wilshire Micro-Cap ETF |
46353 |
0.02% |
-- |
-- |
2017-02-08
|
| USAA Extended Market Index |
50195 |
0.02% |
34767 |
225.35% |
2016-09-30
|
| Master Extended Market Index Series |
50199 |
0.02% |
-- |
-- |
2016-12-31
|
| BNY Mellon Market Completion Fund UC1 |
11710 |
0.01% |
231 |
2.01% |
2016-12-31
|
| Vanguard US Equity Index |
27380 |
-- |
-- |
-- |
2015-06-30
|
| The Vanguard - Total Stk Mkt Idx Trust. CF |
66500 |
-- |
-- |
-- |
2015-09-30
|
| DFA U.S. Micro Cap Portfolio |
72438 |
-- |
-- |
-- |
2015-08-31
|
| DFA U.S. Small Cap Portfolio |
76900 |
-- |
-- |
-- |
2015-08-31
|
| Franklin Biotechnology Discovery Fund |
4709900 |
2.90% |
-643600 |
-12.00% |
2015-09-30
|
| Vanguard Total Stock Mkt Idx |
2339086 |
1.40% |
-- |
-- |
2015-09-30
|
| Vanguard Extended Market Index Fund |
1502968 |
0.90% |
22302 |
1.50% |
2015-09-30
|
| Fidelity Spartan® Extended Mkt Indx Fd |
531478 |
0.30% |
-- |
-- |
2015-08-31
|
| OCP International |
150000 |
0.10% |
150000 |
-- |
2014-09-30
|
| Fidelity Spartan® Total Market Idx Fund |
146638 |
0.10% |
-- |
-- |
2015-08-31
|
| Goodwood SMID Cap Discovery Fund |
141317 |
0.10% |
-258683 |
-64.70% |
2015-09-30
|
| Mellon Capital EB DL Mkt Completion Fund |
130278 |
0.10% |
-- |
-- |
2015-09-30
|
| Vanguard Balanced Index Fund |
88377 |
-- |
-37175 |
-29.60% |
2015-09-30
|
| Vanguard Instl Total Stock Market Index |
81953 |
-- |
-- |
-- |
2015-09-30
|
| Franklin Biotechnology Discovery |
6592600 |
4.00% |
-- |
-- |
2015-07-31
|
